☰

Lee Chao

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Biochemistry, Molecular Biology
Google:
"Lee Chao"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Eric G. Dobrzynski grad student 2001 MUSC
David A. Montanari grad student 2005 MUSC

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chao J, Guo Y, Chao L. (2018) Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity. 2018: 4138560
Yao Y, Li B, Liu C, et al. (2018) Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice. Journal of the American Heart Association. 7: e009562
Chao J, Guo Y, Li P, et al. (2017) Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway. Oxidative Medicine and Cellular Longevity. 2017: 5262958
Guo Y, Li P, Gao L, et al. (2017) Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway. Aging Cell
Chao J, Bledsoe G, Chao L. (2016) Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension
Lin WC, Chen CW, Huang YW, et al. (2015) Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis. Scientific Reports. 5: 12463
Chao J, Bledsoe G, Chao L. (2014) Kallikrein-kinin in stem cell therapy. World Journal of Stem Cells. 6: 448-57
Chao J, Bledsoe G, Chao L. (2014) Tissue kallikrein-kinin therapy in hypertension and organ damage. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrã¨S Des Recherches Pharmaceutiques. 69: 37-57
Li P, Bledsoe G, Yang ZR, et al. (2014) Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis. Immunology. 142: 216-26
Yao Y, Sheng Z, Li Y, et al. (2013) Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 577-91
See more...